Howard Bengele

Title: The Innovations of Howard Bengele

Introduction

Howard Bengele is a notable inventor based in Canton, MA (US), recognized for his contributions to the field of pharmacology and MRI technology. With a total of seven patents to his name, Bengele has made significant advancements in the development of iron oxide complexes.

Latest Patents

Bengele's latest patents focus on polyol and polyether iron oxide complexes that serve as pharmacological and MRI contrast agents. These innovations involve iron oxide complexes and pharmacological compositions that utilize a polysaccharide iron oxide complex. The polysaccharide is a modified polyol, such as a carboxyalkylated reduced dextran. The complex is designed to be stable under terminal sterilization by autoclaving. These compositions are suitable for parenteral administration to treat iron deficiencies or as MRI contrast agents. They are characterized by being substantially immunosilent, providing minimal anaphylaxis, and undergoing minimal dissolution in vivo. Furthermore, the pharmacological compositions contain minimal free iron, which can be quantified through various methods.

Career Highlights

Throughout his career, Howard Bengele has worked with prominent companies in the pharmaceutical and biotechnology sectors, including Amag Pharmaceuticals, Inc. and Advanced Magnetics, Inc. His work has significantly impacted the development of medical technologies and treatments.

Collaborations

Bengele has collaborated with esteemed colleagues such as Ernest V. Groman and Kenneth G. Paul, contributing to the advancement of innovative solutions in his field.

Conclusion

Howard Bengele's contributions to the field of pharmacology and MRI technology through his patents and collaborations highlight his role as a significant innovator. His work continues to influence advancements in medical treatments and diagnostic techniques.